December 20, 2022
Our fragment-to-hit approach that has been featured on the cover of the Journal of Medicinal Chemistry.

What partners say about us:
AiCuris Anti-infective Cures AG, Wuppertal Germany

X-RAY CRYSTALLOGRAPHY: PROTEIN SAMPLE REQUIREMENTS—Our recent blog post, we discuss: Requirements for crystallography-grade protein, QC parameters for better crystallization behaviour, Determinants of protein material for successful crystallographic screenings

November 17, 2022
Our covalent study highlights the advantages of SmartSoak^® for covalent fragment-based drug discovery. Contact us to learn more.

In case you missed the webinar “Fragment-based drug discovery — Hitting Targets Using the Right Chemistry and Expertise Alliances” on how to hit targets using FBDD, you can watch it on CrystalsFirst’s Youtube channel.

Hit Identification in FBDD — Our recent blog post, we discuss: Biophysical screening cascades and the outcomes, Advantages of SmartSoak-enabled crystallographic screens, Importance of high-performance soaking systems for successful campaigns

October 23-25, 2022
CrystalsFirst is attendinng the 30th Protein Structure Determination in Industry (PSDI) 2022 symposium in Eindhoven, Netherlands (Oct 23-25).

October 13, 2022
Our CEO Dr. Serghei Glinca will be presenting at Xtalks on 13th October on cutting-edge applications of X-ray crystallography for hit identification and FBDD.

October 11, 2022
Our fragment-to-hit approach that has been published in the Journal of Medicinal Chemistry.

We have established new labs and offices at Germany’s largest accelerator center — DESY, Hamburg.

March 27, 2022
CrystalsFirst is presenting projects on E3 ligases, kinases, co-crystal soaking, and rapid fragment evolution at the 8th RSC-BMCS Fragment-based Drug Discovery meeting in Cambridge, UK.

March 11, 2022
With our new labs at DESY Campus in Hamburg, we offer flexible data collection services and high quality structure refinements.

January 24, 2022
Take the chance to connect virtually with our CEO Serghei Glinca at the 3rd Alpine Winter Conference to learn how!

March 01, 2021
CrystalsFirst’s CEO Dr. Serghei Glinca will give a presentation at the BioSolveIT DrugSpace Spring Symposium on April 21-22 2021

February 23, 2021
CrystalsFirst to attend the conference “RAS-Targeted Drug Discovery”

January 11, 2021
Dr. Serghei Glinca, CrystalsFirst’s CEO, to participate at the 9th Annual J.P. Morgan HealthCare Partnering Week

September 21, 2020
Meet CrystalsFirst at BioPharma America Digital and learn how our technology can accelerate high-profile drug discovery programs.

July 7, 2020
Dr. Serghei Glinca will present on the next BioSolveIT webinar how CrystalsFirst’s technology helps to unlock chemical matter and new IP in drug discovery projects.

May 6, 2020
CrystalsFirst’s Co-Founder and CEO Dr. Serghei Glinca presents at BIODigital 2020 how our technology unlocks chemical matter on scale

November 1, 2019
Preisträger/innen des Hessischen Gründerpreises 2019

June 12, 2019
Raketenzündung für Start-up „CrystalsFirst“

May 15, 2019
MassChallenge Switzerland Announces its 4th Startup Cohort

January 4, 2018
Science4Life Alumni News des Monats

May 14, 2018
Marburger Startup-Unternehmen CrystalsFirst beschleunigt Arzneistoffsuche

May 18, 2017
Mit stabilen Proteinkristallen die Effizienz der Drug Discovery steigern

April 1, 2017
Gewinner des Science4Life Venture Cups

March 1, 2017
Pitch Club #11 Hessen Ideen—Eventrückblick